The launch of the Retatru vial represents a significant advance in the approach to weight control . This innovative therapy combines dual mechanisms – agonist of the GLP-1 receptor and reduction of the DPP-4 enzyme – providing a different technique for addressing weight concerns. Early clinical data demonstrate substantial efficacy in facilitat… Read More